Literature DB >> 28061951

Role and contribution of pulmonary CD103+ dendritic cells in the adaptive immune response to Mycobacterium tuberculosis.

Vanessa Hui Qi Koh1, See Liang Ng2, Michelle Lay Teng Ang1, Wenwei Lin1, Christiane Ruedl3, Sylvie Alonso4.   

Abstract

Despite international control programmes, the global burden of tuberculosis remains enormous. Efforts to discover novel drugs have largely focused on targeting the bacterium directly. Alternatively, manipulating the host immune response may represent a valuable approach to enhance immunological clearance of the bacilli, but necessitates a deeper understanding of the immune mechanisms associated with protection against Mycobacterium tuberculosis infection. Here, we examined the various dendritic cells (DC) subsets present in the lung and draining lymph nodes (LN) from mice intra-tracheally infected with M. tuberculosis. We showed that although limited in number, pulmonary CD103+ DCs appeared to be involved in the initial transport of mycobacteria to the draining mediastinal LN and subsequent activation of T cells. Using CLEC9A-DTR transgenic mice enabling the inducible depletion of CD103+ DCs, we established that this DC subset contributes to the control of mycobacterial burden and plays a role in the early activation of T cells, in particular CD8+ T cells. Our findings thus support a previously unidentified role for pulmonary CD103+ DCs in the rapid mobilization of mycobacteria from the lungs to the draining LN soon after exposure to M. tuberculosis, which is a critical step for the development of the host adaptive immune response.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD103(+) dendritic cells; Clec9A-DTR; Diptheria-toxin mediated depletion; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 28061951     DOI: 10.1016/j.tube.2016.12.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  7 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis.

Authors:  Stefania Parlato; Teresa Chiacchio; Debora Salerno; Linda Petrone; Luciano Castiello; Giulia Romagnoli; Irene Canini; Delia Goletti; Lucia Gabriele
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

3.  De Novo Fatty Acid Synthesis During Mycobacterial Infection Is a Prerequisite for the Function of Highly Proliferative T Cells, But Not for Dendritic Cells or Macrophages.

Authors:  Philipp Stüve; Lucía Minarrieta; Hanna Erdmann; Catharina Arnold-Schrauf; Maxine Swallow; Melanie Guderian; Freyja Krull; Alexandra Hölscher; Peyman Ghorbani; Jochen Behrends; Wolf-Rainer Abraham; Christoph Hölscher; Tim D Sparwasser; Luciana Berod
Journal:  Front Immunol       Date:  2018-04-05       Impact factor: 7.561

Review 4.  The Role of Innate Immunity in Pulmonary Infections.

Authors:  Huihui Zhang; Fang He; Pan Li; Philip R Hardwidge; Nengzhang Li; Yuanyi Peng
Journal:  Biomed Res Int       Date:  2021-01-22       Impact factor: 3.411

Review 5.  Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion.

Authors:  Hongmin Kim; Sung Jae Shin
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

Review 6.  Microbial Metabolites in the Maturation and Activation of Dendritic Cells and Their Relevance for Respiratory Immunity.

Authors:  Kayla R Wilson; Elise Gressier; Malcolm J McConville; Sammy Bedoui
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

7.  Mycobacterium bovis Bacillus Calmette-Guérin-Infected Dendritic Cells Induce TNF-α-Dependent Cell Cluster Formation That Promotes Bacterial Dissemination through an In Vitro Model of the Blood-Brain Barrier.

Authors:  Trey E Gilpin; Fruzsina R Walter; Melinda Herbath; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2021-07-28       Impact factor: 5.426

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.